March 24 Update: CryoStork facilities are continuing to provide service. Based on our status as both a transportation and support service for healthcare, it is clear our Cryoport-Irvine operation is exempt from the California directive and is continuing to operate as normal.
We would like to make you aware of the proactive steps we are taking to mitigate risk and avoid disruptions to our clinic partners during the global COVID-19 pandemic.
CryoStork is a division of Cryoport Systems, Inc., which provides supply chain services for biopharmaceutical and reproductive medicine organizations around the world. Cryoport has implemented an all-inclusive business continuity plan focused on meeting the needs of our employees, clients and their patients, distributors, and suppliers.
Furthermore, Cryoport has recently developed a validated cleaning methodology that reduces environmental contaminants to our equipment by 99.9999%.
Rest assured Cryoport’s team is actively monitoring the situation and will continue to do so until the risks subside. We are committed to embracing all challenges COVID-19 creates for Cryoport, CryoStork, or our clients.
As a clinic partner, you are a very important and valued part of our service network and we want to assure you that you can depend on Cryoport. We will continue to proactively communicate any relevant information about our COVID-19 response plan, and we encourage you to reach out to us with any questions or concerns you may have.